An Audit of Vancomycin in the MMUH

Vancomycin is a reserve antimicrobial at the Mater Misericordiae University Hospital (MMUH), indicated for the specific treatment of Gram-positive infections resistant or intolerant of standard beta-lactam therapy. Vancomycin therapy requires monitoring of blood levels to minimise the risks of nephrotoxicity and ensure its efficacy. This poster summarises an audit of vancomycin undertaken at the hospital to ascertain the appropriateness of vancomycin TDM in the MMUH with a view to establishing dosing and monitoring guidelines to improve current practice.

To view this poster, click on the 'view PDF' icon below. [Please note that some text may have been cropped in the file conversion process.]

View PDF.

You will need Adobe's Acrobat Reader to view these files. To download Acrobat Reader click on the image below.